Jim Cramer warns AI labs face a litigation bill no insurer will cover
As seen on the 24/7 Wall St. homepage on September 10, 2026.
Cramer is pointing at the AI risk nobody prices in: insurers backing away from copyright and liability exposure, leaving the leading labs to absorb litigation costs directly. That bill lands on the private valuations investors are chasing.
Can OpenAI and Anthropic get insurance?? Long before they kill us, the plaintiffs' lawyers will kill them without it
- Replies19
- Reposts2
- Likes48
Continue ReadingShow less
Jim Cramer's question about whether OpenAI and Anthropic can obtain insurance is pointed at a real and growing problem: major insurers have grown wary of underwriting the copyright and liability exposure that comes with training and deploying large language models. If the leading labs cannot find carriers willing to take on that risk, they absorb every lawsuit cost directly from their own balance sheets.
That matters for investors because the private valuations both companies carry are built on assumptions about future revenue rather than reserves for nine-figure legal settlements. A sustained wave of successful plaintiffs' suits, without an insurance backstop to spread the losses, erodes the equity cushion that justifies those valuations faster than any competitive threat from a rival model.
Sponsored
Are You Ready To Retire, Or Years Behind?
Most Americans suspect they're behind on retirement and never find out. Advisor.com's free matching tool pairs you in about three minutes with a vetted fiduciary advisor who can help you with investing, taxes, retirement, estate planning, and more. No minimums. No sales call. Find out where you stand.
Ongoing copyright suits from authors, publishers, and other rights holders mean the courtroom exposure is not hypothetical. Cramer's framing flips the usual AI safety debate: the existential risk he is flagging is financial and legal, arriving well ahead of any science fiction scenario.
For investors with exposure to funds or vehicles tied to either company's private valuation, the question to press is simple: what is the litigation reserve, and who, if anyone, is carrying the insurance.